Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor - sparing strategy: Results from the multicenter study with nevirapine and kaletra (MULTTNEKA)

Eugenia Negredo, Óscar Miró, Benjamí Rodríguez-Santiago, Gloria Garrabou, Carla Estany, Angels Masabeu, Lluís Force, Pilar Barrufet, Josep Cucurull, Pere Domingo, Carlos Alonso-Villaverde, Anna Bonjoch, Constanza Morón, Nuria Pérez-Álvarez, Bonaventura Clotet, A. Alonso, V. Boix, J. A. Cartón, J. de la Torre, S. EchevarríaM. J. Galindo, F. Gutiérrez, V. Roca

Research output: Contribution to journalArticleResearchpeer-review

44 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor - sparing strategy: Results from the multicenter study with nevirapine and kaletra (MULTTNEKA)'. Together they form a unique fingerprint.

Medicine & Life Sciences